cimetidine has been researched along with Parathyroid Neoplasms in 10 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Parathyroid Neoplasms: Tumors or cancer of the PARATHYROID GLANDS.
Excerpt | Relevance | Reference |
---|---|---|
"Recent evidence suggests that cimetidine given pre-operatively in primary hyperparathyroidism (1 degree HPT) might cause structural changes in parathyroid glands, while its suppressive effects on the disease are disputable." | 7.67 | The effect of cimetidine on parathyroid function and histopathology in primary hyperparathyroidism. ( Ikkos, DG; Nikou, AD; Pappas, AD; Singhellakis, PN; Sklivagou, NG; Sotsiou, FC; Vambouka, C, 1987) |
"In twelve patients with primary hyperparathyroidism the raised parathyroid hormone (PTH) levels consistently returned to normal with cimetidine ("Tagamet"), 300 mg four times a day, orally." | 7.66 | Effect of cimetidine on circulating parathyroid hormone in primary hyperparathyroidism. ( Ackroyd, FW; Garcia, M; Sherwood, JK, 1980) |
"We studied in vitro the presence of histamine and the effect of histamine and its antagonists on cAMP accumulation in parathyroid tissue (parathyroid adenoma or hyperplasia) from patients with primary hyperparathyroidism." | 7.66 | Histamine and human parathyroid adenoma: effect on adenosine 3',5'-monophosphate accumulation in vitro. ( Abbound, HE; Dousa, TP; Edis, AJ; Heath, H; Zimmerman, D, 1981) |
"Cimetidine has been shown to lower circulating PTH levels effectively by causing an intraglandular rearrangement of PTH peptides in human parathyroid tissue in instances of primary hyperparathyroidism." | 5.27 | The preoperative use of cimetidine as a means of preventing symptomatic hypocalcemia following a parathyroid operation. ( Ackroyd, FW; Garcia, M; Minervini, D; Seiden, EF; Sherwood, JK; Willis, IH, 1983) |
"The effect of cimetidine on basal and histamine-induced PTH secretion was tested using single cell suspensions obtained from (a) primary parathyroid adenomas, and (b) secondary hyperplastic parathyroid tissue from patients undergoing chronic hemodialysis." | 3.67 | Effect of cimetidine on basal and histamine-induced secretion of parathyroid hormone in vitro. ( Beyer, J; Krause, U; Rothmund, M; Schärfe, T; Wagner, PK, 1984) |
"Recent evidence suggests that cimetidine given pre-operatively in primary hyperparathyroidism (1 degree HPT) might cause structural changes in parathyroid glands, while its suppressive effects on the disease are disputable." | 3.67 | The effect of cimetidine on parathyroid function and histopathology in primary hyperparathyroidism. ( Ikkos, DG; Nikou, AD; Pappas, AD; Singhellakis, PN; Sklivagou, NG; Sotsiou, FC; Vambouka, C, 1987) |
"In twelve patients with primary hyperparathyroidism the raised parathyroid hormone (PTH) levels consistently returned to normal with cimetidine ("Tagamet"), 300 mg four times a day, orally." | 3.66 | Effect of cimetidine on circulating parathyroid hormone in primary hyperparathyroidism. ( Ackroyd, FW; Garcia, M; Sherwood, JK, 1980) |
"We studied in vitro the presence of histamine and the effect of histamine and its antagonists on cAMP accumulation in parathyroid tissue (parathyroid adenoma or hyperplasia) from patients with primary hyperparathyroidism." | 3.66 | Histamine and human parathyroid adenoma: effect on adenosine 3',5'-monophosphate accumulation in vitro. ( Abbound, HE; Dousa, TP; Edis, AJ; Heath, H; Zimmerman, D, 1981) |
"Cimetidine has been shown to lower circulating PTH levels effectively by causing an intraglandular rearrangement of PTH peptides in human parathyroid tissue in instances of primary hyperparathyroidism." | 1.27 | The preoperative use of cimetidine as a means of preventing symptomatic hypocalcemia following a parathyroid operation. ( Ackroyd, FW; Garcia, M; Minervini, D; Seiden, EF; Sherwood, JK; Willis, IH, 1983) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sherwood, JK | 2 |
Ackroyd, FW | 2 |
Garcia, M | 2 |
Friesen, SR | 1 |
Hermreck, AS | 1 |
Brackett, CE | 1 |
Schimke, RN | 1 |
Abbound, HE | 1 |
Zimmerman, D | 1 |
Edis, AJ | 1 |
Heath, H | 1 |
Dousa, TP | 1 |
Brennan, MF | 1 |
Willis, IH | 1 |
Minervini, D | 1 |
Seiden, EF | 1 |
Wagner, PK | 1 |
Krause, U | 1 |
Schärfe, T | 1 |
Beyer, J | 1 |
Rothmund, M | 1 |
Klein, I | 1 |
Lehotay, DC | 1 |
Watson, CG | 1 |
Rogerson, B | 1 |
Levey, GS | 1 |
Gasparoni, P | 1 |
Rota, G | 1 |
Fioretti, D | 1 |
Lo Giudice, C | 1 |
Manente, P | 1 |
Valmachino, G | 1 |
Conte, N | 1 |
Sasaki, H | 1 |
Miyake, K | 1 |
Okumura, M | 1 |
Eimoto, T | 1 |
Sotsiou, FC | 1 |
Singhellakis, PN | 1 |
Nikou, AD | 1 |
Pappas, AD | 1 |
Vambouka, C | 1 |
Sklivagou, NG | 1 |
Ikkos, DG | 1 |
1 review available for cimetidine and Parathyroid Neoplasms
Article | Year |
---|---|
Primary hyperparathyroidism.
Topics: Adenoma; Aged; Cimetidine; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Male; | 1983 |
9 other studies available for cimetidine and Parathyroid Neoplasms
Article | Year |
---|---|
Effect of cimetidine on circulating parathyroid hormone in primary hyperparathyroidism.
Topics: Adenoma; Administration, Oral; Aged; Cimetidine; Female; Guanidines; Humans; Hypercalcemia; Hyperpar | 1980 |
Case reports; Cimetidine in the management of synchronous crises of MEA I.
Topics: Adrenal Gland Neoplasms; Adult; Cimetidine; Female; Guanidines; Humans; Multiple Endocrine Neoplasia | 1980 |
Histamine and human parathyroid adenoma: effect on adenosine 3',5'-monophosphate accumulation in vitro.
Topics: Adenoma; Cimetidine; Cyclic AMP; Female; Histamine; Humans; In Vitro Techniques; Isoproterenol; Male | 1981 |
The preoperative use of cimetidine as a means of preventing symptomatic hypocalcemia following a parathyroid operation.
Topics: Adenoma; Calcium; Cimetidine; Humans; Hypocalcemia; Parathyroid Glands; Parathyroid Hormone; Parathy | 1983 |
Effect of cimetidine on basal and histamine-induced secretion of parathyroid hormone in vitro.
Topics: Adenoma; Cimetidine; Dose-Response Relationship, Drug; Histamine; Humans; Hyperparathyroidism; Hyper | 1984 |
Human parathyroid adenoma adenylate cyclase: stimulation by histamine that is blocked by cimetidine.
Topics: Adenoma; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Cimetidine; Dose-Response Relationship, Dru | 1981 |
[Cimetidine and primary hyperparathyroidism: failure of reduction of blood levels of parathyroid hormone in 5 cases of primary hyperparathyroidism].
Topics: Adult; Cimetidine; Female; Guanidines; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid H | 1981 |
[Failure of cimetidine and etidronate disodium to suppress parathyroid hormone level and hypercalcemia in primary hyperparathyroidism].
Topics: Adenoma; Aged; Alkaline Phosphatase; Cimetidine; Etidronic Acid; Humans; Hypercalcemia; Hyperparathy | 1988 |
The effect of cimetidine on parathyroid function and histopathology in primary hyperparathyroidism.
Topics: Adenoma; Adolescent; Adult; Aged; Calcium; Cimetidine; Female; Humans; Hyperparathyroidism; Hyperpla | 1987 |